Prostate cancer, insulin, and androgen deprivation therapy
2003

Prostate Cancer and Insulin Levels

Sample size: 149 publication Evidence: moderate

Author Information

Author(s): Stattin P, Kaaks R

Primary Institution: UmeƄ University Hospital

Hypothesis

Does insulin level influence the risk of prostate cancer?

Conclusion

The study found no significant association between prostate cancer risk and insulin levels in blood samples taken before diagnosis.

Supporting Evidence

  • Insulin levels were found to be higher in high-risk prostate cancer patients according to previous studies.
  • The current study did not find a significant increase in insulin levels in relation to prostate cancer risk.
  • Different treatments for prostate cancer may have influenced insulin measurements.

Takeaway

The researchers looked at insulin levels in men with prostate cancer and found that higher insulin levels didn't mean a higher risk of cancer.

Methodology

Reanalysis of data from a previous study comparing insulin levels in prostate cancer patients categorized by risk.

Potential Biases

Potential bias due to the timing of blood sample collection relative to cancer treatment.

Limitations

The study only analyzed data from men diagnosed with prostate cancer and did not account for the effects of therapy on insulin levels.

Participant Demographics

Men diagnosed with prostate cancer, categorized into high and low risk based on tumor characteristics.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601351

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication